Abstract-Renal endothelin-1 participates in sodium and water handling, and its urinary excretion is increased in sodium-retentive states. We compared the cortical and medullary renal expression of prepro-endothelin-1, endothelinconverting enzyme-1, and endothelin type A and type B receptors in patients who underwent nephrectomy after normal (108 mmol/d NaCl; nϭ6) or low (20 mmol/d NaCl; nϭ6) sodium diet and investigated whether sodium exerts a direct role on endothelin receptor binding in vitro. With normal sodium diet prepro-endothelin-1 mRNA was 3-fold higher in renal medulla than in cortex (PϽ0.01), whereas endothelin-converting enzyme-1 mRNA was equally distributed. Endothelin-1 receptor density was 2-fold higher in renal medulla than in cortex (PϽ0.05). Type B was the main receptor subtype in both regions. In the renal cortex, low sodium diet caused a 194% increase in prepro-endothelin-1 mRNA (PϽ0.05), whereas endothelin-converting enzyme-1 type B and type A receptors remained unchanged. In contrast, in the renal medulla the increase in prepro-endothelin-1 mRNA (ϩ30%, PϽ0.05) was associated with a selective increase in type B receptor for both mRNA expression (ϩ37%, PϽ0.05) and binding density (ϩ55%, PϽ0.05). Increasing in vitro sodium concentrations between 154 and 308 mmol/L significantly enhanced type B receptor density (PϽ0.05) and affinity (PϽ0.05). In conclusion, during low sodium diet, renal prepro-endothelin-1 synthesis increases mainly in the renal cortex (where no changes in receptors occur), whereas type B receptor is selectively enhanced in the renal medulla. 
R enal endothelin (ET)-1 is produced by vascular endothelium in the cortex, including glomerular capillaries, arterioles, and peritubular capillaries, and by tubular epithelial cells in the inner medulla. 1,2 These 2 compartments represent 2 distinct systems, both involved in volume homeostasis. ET-1 produced in the vasculature by endothelial cells is able to reduce blood flow at the renal cortex by acting on endothelin type A (ET A ) receptor subtype. 3 This vascular ET A -mediated effect results in increased sodium reabsorption in both humans 3, 4 and experimental animals. 5 Conversely, ET-1 produced by tubular epithelial cells inhibits arginine vasopressin (AVP)-stimulated osmotic water permeability in inner medullary collecting ducts 6 -8 via endothelin type B (ET B ) receptor subtype, 5, 9 thus increasing free water clearance. 2 There is in vitro evidence that the increased osmolality increases preproET-1 (ppET-1) mRNA expression and ET-1 synthesis in epithelial tubular cells. 10, 11 In vivo, an increased renal ET-1 production has been found in pathophysiological and clinical conditions characterized by increased medulla osmolarity, such as dehydrated physical exercise, 12 low sodium diet, 2 and heart failure. 13 However, although cortical and medullary ET-1 systems participate differently in sodium and water handling, no studies exist comparing the activation of the ET-1 system in the 2 renal regions in the sodium-retentive states. Moreover, despite the fact that the use of ET-1 receptor antagonist has been proposed in heart failure, 14 -16 no information is available as to whether the increased local ET-1 synthesis is associated with a consensual increase in receptor synthesis or whether it may cause downregulation of its specific receptors.
Therefore, the aims of this study are to compare the effects of low sodium diet on the expression of the various ET-1 system components (ppET-1, endothelin-converting enzyme [ECE]-1, ET A , and ET B ) in the cortex and in renal medulla and to investigate whether sodium might play a direct role on endothelin receptor binding density and affinity.
Methods

Subjects Investigated and Experimental Protocol
Twelve patients affected by polar tumor and listed for elective nephrectomy were investigated. No subject was a smoker or had taken any drug for at least 4 weeks. Patients with hypertension, ischemic heart disease, heart failure, renal failure, abnormal liver function tests or diabetes were excluded. The study was approved by the local review committee of the University of Florence, and all subjects gave their informed, written consent.
During the week preceding surgery, patients were randomized to receive a 7-day period of the same basic diet, with either normal (108 mmol/d NaCl; nϭ6) or low (20 mmol/d NaCl; nϭ6) sodium intake. Urine and plasma samples for the determination of sodium, creatinine, and plasma renin activity (PRA) were taken daily during the last 3 days of each diet regimen (Table 1) .
Transmural kidney specimens, containing both cortex and medulla, were cut from the pole opposite the tumor and fixed in 4% paraformaldehyde for in situ hybridization studies. In addition, separated specimens of whole medulla (containing both inner and outer medulla) and cortex were dissected immediately after nephrectomy and frozen in liquid nitrogen for binding and RT-PCR studies.
Receptor Binding Studies
Cell membranes were obtained from homogenated tissue as previously described. 17 Competition and kinetic studies were performed in the presence of increasing concentrations of NaCl or NaH 2 PO 4 (0, 77, 154, 231, and 308 mmol/L). Experiments were carried out in triplicate, and separate curves for renal cortex and medulla were obtained in each patient.
Equilibrium Binding Studies
Cell membranes (250 g/mL) were incubated with 125 I-ET-1 (100 pmol/L, 2000 Ci/mmol) (Amersham) and increasing concentrations of unlabeled ET-1 (0 to 1 mol/L) or selective ET A (BQ123, 0 to 100 mol/L) and ET B (BQ788, 0 to 100 mol/L) antagonists for 120 minutes at 22°C in a final volume of 0.2 mL. 17 The content was then rapidly filtered through glass fiber filters (Whatman GF/C). Binding data were analyzed using a nonlinear fitting computer program (LIGAND). 18 
Kinetic Analysis
The kinetics of association of 125 I-ET-1 (100 pmol/L) to cell membranes (250 g/mL) were evaluated as previously described. 19 
RT-PCR Analysis
Levels of ppET-1, ECE-1, ET A , and ET B transcripts were quantified with reverse transcription-polymerase chain reaction (RT-PCR) using specific primers (Table 2 ) with GAPDH as the internal standard as previously described. 17 The efficiency of amplification of each primer pair was calculated beforehand from the slope of the semilogarithmic relationship between cycles of amplification (26 to 44) and amplification products (23% for GAPDH, 23% for ppET-1, 22% for ECE-1, and 22% for both ET A and ET B receptors) ( Figure  1 ). All RT-PCR studies were performed in triplicate in all subjects investigated.
In Situ Hybridization Studies
In situ hybridization studies were performed as previously described 2 using specific cDNA probes for ET A and ET B receptor subtypes (ET A , American Type Culture Collection, ATCC 105194, and ET B , ATCC 1250426) and for GAPDH (ATCC 57090).
Statistical Analysis
Data are presented as meanϮSD. Comparisons of a single observation between groups were made with ANOVA and 2-tailed t tests. All statistical analyses were performed with BMDP statistical software (BMDP Statistical Software, Inc).
Results
Renal ET-1 System
RT-PCR showed that the ppET-1/GAPDH ratio was 3-fold higher in renal medulla than in cortex (1.01Ϯ0.1 versus 0.31Ϯ0.24, respectively; PϽ0.01), whereas there was a comparable presence of ECE-1 mRNA in the 2 regions (ECE-1/GAPDH ratios of 0.85Ϯ0.45 and 0.78Ϯ0.44, respectively) ( Figure 2A ).
ET B mRNA was the prevalent receptor transcript in both medulla (1.21Ϯ0.08 and 0.39Ϯ0.12 for ET B /GAPDH and ET A /GAPDH ratios, respectively) and renal cortex (0.95Ϯ0.33 and 0.45Ϯ0.14, respectively) ( Figure 2A ). In situ hybridization studies showed that mRNA for ET B receptor was mainly expressed by tubular epithelial cells in renal medulla, whereas the ET A subtype was almost exclusively localized in the endothelial cells of peritubular vessels (Figure 2B) .
With binding studies, ET-1 receptor density was 2-fold higher in renal medulla than in cortex (127Ϯ13 versus 59Ϯ9 fmol/mg protein, PϽ0.05) ( Table 3) . Again with binding studies, receptor population was almost exclusively represented by the ET B subtype in both districts (Ͼ80%) ( Figure  3) , with a 2.3-fold higher maximum binding (Bmax) in renal medulla than in renal cortex (Table 3 ). No differences in receptor affinity were observed between renal medulla and renal cortex.
Effect of Low Sodium Diet
In renal cortex, only mRNA for ppET-1 was markedly increased (ϩ194% versus normal sodium diet) whereas mRNAs for ECE-1 and receptor subtypes remained unchanged ( Figure 4) . No changes in receptor binding were found in renal cortex (Table 3) .
Conversely, in renal medulla, both ppET-1 and ET B genes were significantly enhanced (ϩ30% and ϩ37%, respectively; PϽ0.05 for both) without any changes in ECE-1 and ET A transcripts. Binding studies confirmed the selective increase in ET B receptor density in renal medulla during low sodium diet (ϩ55% versus normal sodium diet) with no modifications in the ET A subtype (Table 3, Figure 5 ).
Effect of Sodium In Vitro
ET B receptor density and affinity showed a sodium-dependent increase in renal medullary membranes obtained from patients on normal sodium diet (Table 3, Figure 6 ). The increase was significant for NaCl concentrations greater than 154 mmol/L because, at 154 mmol/L, ET B receptor density was increased by 15% versus NaCl-free buffer (NS), whereas at 231 and 308 mmol/L increased by 28% (PϽ0.05 versus NaCl-free buffer) and 49% (PϽ0.05 versus both NaCl-free buffer and 154 mmol/L NaCl).
Likewise, the binding affinity remained almost unchanged versus NaCl-free buffer up to 154 mmol/L NaCl (1.5-fold, NS), and was 3.2-fold and 3.8-fold enhanced at 231 and 308 mmol/L NaCl, respectively (PϽ0.05 versus NaCl-free and 154 mmol/L NaCl for both) ( Table 3 ).
In addition, the same effect was observed with membranes isolated from renal cortex. The relationship between the KϫR product of ET-1 binding (a unitless measure of the amount of 
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ligand-receptor binding) and sodium concentration in the incubation medium showed a sigmoid pattern with a maximum rate of increase for sodium concentrations ranging between 154 and 308 mmol/L, which corresponded to a 4-fold increase in ET-1 binding efficiency ( Figure 7 ). The enhancement of binding efficiency was not attributable to chloride because similar results were obtained when NaH 2 PO 4 was used instead of NaCl ( Figure 7) .
Discussion
The present study shows that during low sodium diet (1) the synthesis of renal ppET-1 is increased mainly in the cortex, where no changes in endothelin receptors occur, whereas (2) ET B receptor density selectively increases in renal medulla, and, moreover, that (3) sodium in vitro directly enhance ET B receptor density and affinity. Increased ppET-1 mRNA expression in the endothelial cells of the peritubular capillary network and in epithelial cells of the medullary collecting tubules during low sodium diet was previously reported by our group. 2 In the same study, the increased ppET-1 mRNA expression was associated with an increased renal ET-1 production and urinary ET-1 excretion linearly related to sodium retention. 2 The present study extends these results and offers new insights into the role of ET-1 in sodium retentive states in humans. The comparison between cortex and renal medulla of ppET-1 mRNA expression at RT-PCR shows that, during low sodium diet, the ppET-1 gene is enhanced to a greater extent in renal cortex, where the vascular component is highly represented, than in renal medulla. Moreover, mRNA studies performed in cortical tissue have revealed that the ET A receptor, previously found in homogenates from renal cortex, 20, 21 is mainly localized in the vasculature (in situ hybridization) and is not downregulated during low sodium diet (RT-PCR studies). Sodium reabsorption mainly occurs at the proximal tubule with an active process. In addition, when extracellular volume is contracted, as during low sodium diet, and postglomerular resistances are increased to maintain the glomerular filtration rate, the decreased hydrostatic pressure and the increased colloid osmotic pressure in peritubular capillaries further enhance the rate of sodium reabsorption at the proximal tubule. The wide range of increase in ppET-1 expression in renal cortex (ϩ194%) might contribute to reducing cortical blood flow through ET A receptors, 4, 5, 22 enhancing sodium and water reabsorption at the proximal tubule. The reduction in cortical blood flow also attenuates the flow in the vasa recta, so that the reduced washout of osmolytes in renal medulla increases intratubular sodium concentration and passive sodium reabsorption at the thin ascending limb of Henle's loop. 23, 24 Therefore, the high ppET-1 overexpression in the cortex at low sodium diet, without changes in vascular ET A receptor, indicate that, at normal sodium diet, the ET A receptor population exceeds the physiological requirement and that, during low sodium diet, ET-1 contributes to sodium reabsorption mainly via the ET A -mediated reduction of cortical blood flow and, finally, that ET-1 does not downregulate the ET A receptor.
Unlike in the cortex, in renal medulla the increased ppET-1 transcript (30%) is paralleled by selective ET B receptor gene overexpression (37%) with selective increase in the number of ET B binding sites (55%). The mechanisms responsible for the increased medullary de novo synthesis of ET B receptors during low sodium diet remain to be investigated, and a possible role for medulla hyperosmolarity can only be postulated. In situ hybridization indicates that the ET B receptor gene in the renal medulla is expressed by epithelial cells of distal tubules and collecting ducts, where previous autoradiographic studies had localized the receptor protein. 19 ET B receptors in inner medullary collecting ducts mediate the ET-1 inhibitory effect on AVP-stimulated osmotic water permeability. 6, 25, 26 In addition, ET B stimulation also inhibits sodium reabsorption along the thick ascending limb. 5, 27 ET Bselective overexpression in the renal medulla during low sodium diet may modulate ET A -mediated sodium retention, at the same time contrasting AVP-mediated water reabsorption and possible hyponatremia in clinical conditions characterized by nonosmotic AVP secretion, such as heart failure.
During a low sodium diet, the efficiency of ET B receptor binding in renal medulla also appears to be magnified, in addition to increased ET B receptor synthesis. In vitro studies have indeed shown a direct effect of increased local sodium concentration on ET B receptor density and affinity in medullary membranes. The maximum effect of sodium on ET B receptors in vitro is evident between 154 and 308 mmol/L ( Figure 7) , ie, within the range of sodium concentration in renal medulla. 28 This effect is observed in membranes obtained from patients at both low and normal sodium diet and is not due to chloride in itself because the same pattern of response is observed when sodium phosphate is used.
The adaptation of ET B receptors to different sodium intake is not an isolated result. Type I angiotensin (Ang) II receptors in the kidney also exhibit physiological adaptation during chronic changes in sodium intake because sodium restriction increased renal Ang II receptor density and AT1 mRNA levels in the 2 main sites of sodium reabsorption, proximal tubules 29, 30 and the medullary thick ascending limb of loop of Henle. 31 Conversely, a high salt diet was associated with a downregulation of AT1 receptors. 32 Therefore, during low sodium diet the upregulation of angiotensin II receptors cooperates with angiotensin II formation to enhance sodium retention. In the same condition, the endothelin-1 system seems to operate as a modulating system because it selectively activates the ET B receptor subtype, which causes natriuresis and increases free water clearance.
Experiments performed in rats indicated that AT1 receptor upregulation during low sodium diet is Ang II-dependent because it was prevented by losartan treatment. 31 At variance with Ang II, endothelin-1 seems not responsible for receptor upregulation because, according to the present findings, ET B receptor is not enhanced in the cortex where ET-1 is overexpressed to a greater extent than in medulla. Moreover, the in vivo increase in ET B receptor binding efficiency during low sodium diet is reproduced in vitro by sodium concentrations expected to be present in renal medulla. Sodium was reported to interact at the level of the second transmembrane domain of the other 7 membrane domain receptors, such as the D2 receptor 33 and the bradykinin B2 receptor, 34 resulting in enhanced stability of the agonist-receptor complex and enhanced binding efficiency. 35 The present study does not clarify the responsible mechanism at the molecular level but, for the first time, indicates that only the type B of the 2 endothelin receptors dynamically adapts its binding efficiency in a range of sodium concentration that is physiological for renal medulla.
In conclusion, present findings indicate that the endothelin system in the kidney is regulated by sodium intake and that the local levels of sodium directly modulate ET B receptor density and affinity, resulting in a different adaptations of the cortex and renal medulla to low sodium diet.
Perspectives
The enhanced ET-1 synthesis with increased efficiency of the ET B receptor in human renal medulla during low sodium diet shows a dynamic modulation of the renal ET-1 system in a physiological condition of sodium retention. ET B enhances free water clearance so that medullary ET B receptor adaptation might indeed play a key role in counteracting cortical ET A -mediated sodium retention and AVP-mediated water reabsorption in sodium retentive states.
These results might also bear implications for the proposed therapeutic use of endothelin receptor antagonist in heart failure. Notwithstanding the fact that acute nonselective ET-1 antagonism showed hemodynamic benefits in heart failure patients, 36, 37 the ET B blockade might be responsible for the early and sustained increase in body weight and frequency of edema caused by fluid retention, recently observed during chronic mixed ET A /ET B receptor blockade. 38 It is worth recalling that, in experimental heart failure, only the use of selective ET A antagonists was shown to improve diuresis, whereas no effects were observed following the administration of nonselective ET-1 antagonists. 39, 40 Therefore, the enhanced ET B efficiency might play a relevant role, especially under conditions of marked sodium retention. 
